Showing 70,861 - 70,880 results of 112,989 for search '(( 5 ((mean decrease) OR (a decrease)) ) OR ( a ((fold decrease) OR (point decrease)) ))', query time: 1.30s Refine Results
  1. 70861

    Table 1_Nutritionally adequate, healthy, and climate-friendly diets following the Nordic Nutrition Recommendations 2023: an optimization study for Norway.xlsx by Julie Lengle (21356141)

    Published 2025
    “…</p>Results<p>Optimizing the diet to meet nutrient and health constraints alone resulted in a modest decrease in GWP (NNR2023); retaining ruminant meat consumption (Ruminant) impeded the reduction (−9% vs. 0%). …”
  2. 70862

    Multicomponent System of NPS-1034, an Orally Administered Lung Cancer Drug Candidate, with Sulfonic Acids and Solid State Characterization by Jangmi Lee (1875595)

    Published 2016
    “…Sulfonic acid salts of NPS-1034 decreased the melting point of NPS-1034 as much as −155.43 °C. …”
  3. 70863

    Multicomponent System of NPS-1034, an Orally Administered Lung Cancer Drug Candidate, with Sulfonic Acids and Solid State Characterization by Jangmi Lee (1875595)

    Published 2016
    “…Sulfonic acid salts of NPS-1034 decreased the melting point of NPS-1034 as much as −155.43 °C. …”
  4. 70864

    Multicomponent System of NPS-1034, an Orally Administered Lung Cancer Drug Candidate, with Sulfonic Acids and Solid State Characterization by Jangmi Lee (1875595)

    Published 2016
    “…Sulfonic acid salts of NPS-1034 decreased the melting point of NPS-1034 as much as −155.43 °C. …”
  5. 70865

    Multicomponent System of NPS-1034, an Orally Administered Lung Cancer Drug Candidate, with Sulfonic Acids and Solid State Characterization by Jangmi Lee (1875595)

    Published 2016
    “…Sulfonic acid salts of NPS-1034 decreased the melting point of NPS-1034 as much as −155.43 °C. …”
  6. 70866

    Multicomponent System of NPS-1034, an Orally Administered Lung Cancer Drug Candidate, with Sulfonic Acids and Solid State Characterization by Jangmi Lee (1875595)

    Published 2016
    “…Sulfonic acid salts of NPS-1034 decreased the melting point of NPS-1034 as much as −155.43 °C. …”
  7. 70867
  8. 70868

    Differentiation of mammary gland epithelial cells in control (<i>Ctr</i>) and <i>Miz1</i>Δ<i>POZ</i> tissue and in HC11 cells with reduced levels of Miz1. by Adrián Sanz-Moreno (172726)

    Published 2014
    “…The film was exposed 1 and 5 minutes, respectively. (<b>G</b>) PCR and (<b>H</b>) Western blots revealed a down-regulation of ß-casein when Miz1 concentration is decreased. …”
  9. 70869

    Table_2_PDIA2 Bridges Endoplasmic Reticulum Stress and Metabolic Reprogramming During Malignant Transformation of Chronic Colitis.docx by Jie Tao (227070)

    Published 2022
    “…</p>Results<p>AOM/DSS treatment induced 38 tumors in 10 mice at the 14th week with the mean tumor size 9.35 ± 3.87 mm<sup>2</sup>, which was significantly decreased to 5.85 ± 0.95 mm<sup>2</sup> by the ER stress inhibitor 4-phenylbutyric acid (4PBA). …”
  10. 70870

    Image_3_PDIA2 Bridges Endoplasmic Reticulum Stress and Metabolic Reprogramming During Malignant Transformation of Chronic Colitis.tif by Jie Tao (227070)

    Published 2022
    “…</p>Results<p>AOM/DSS treatment induced 38 tumors in 10 mice at the 14th week with the mean tumor size 9.35 ± 3.87 mm<sup>2</sup>, which was significantly decreased to 5.85 ± 0.95 mm<sup>2</sup> by the ER stress inhibitor 4-phenylbutyric acid (4PBA). …”
  11. 70871

    Image_4_PDIA2 Bridges Endoplasmic Reticulum Stress and Metabolic Reprogramming During Malignant Transformation of Chronic Colitis.tif by Jie Tao (227070)

    Published 2022
    “…</p>Results<p>AOM/DSS treatment induced 38 tumors in 10 mice at the 14th week with the mean tumor size 9.35 ± 3.87 mm<sup>2</sup>, which was significantly decreased to 5.85 ± 0.95 mm<sup>2</sup> by the ER stress inhibitor 4-phenylbutyric acid (4PBA). …”
  12. 70872

    Image_7_PDIA2 Bridges Endoplasmic Reticulum Stress and Metabolic Reprogramming During Malignant Transformation of Chronic Colitis.tif by Jie Tao (227070)

    Published 2022
    “…</p>Results<p>AOM/DSS treatment induced 38 tumors in 10 mice at the 14th week with the mean tumor size 9.35 ± 3.87 mm<sup>2</sup>, which was significantly decreased to 5.85 ± 0.95 mm<sup>2</sup> by the ER stress inhibitor 4-phenylbutyric acid (4PBA). …”
  13. 70873

    Table_3_PDIA2 Bridges Endoplasmic Reticulum Stress and Metabolic Reprogramming During Malignant Transformation of Chronic Colitis.docx by Jie Tao (227070)

    Published 2022
    “…</p>Results<p>AOM/DSS treatment induced 38 tumors in 10 mice at the 14th week with the mean tumor size 9.35 ± 3.87 mm<sup>2</sup>, which was significantly decreased to 5.85 ± 0.95 mm<sup>2</sup> by the ER stress inhibitor 4-phenylbutyric acid (4PBA). …”
  14. 70874

    Image_1_PDIA2 Bridges Endoplasmic Reticulum Stress and Metabolic Reprogramming During Malignant Transformation of Chronic Colitis.jpeg by Jie Tao (227070)

    Published 2022
    “…</p>Results<p>AOM/DSS treatment induced 38 tumors in 10 mice at the 14th week with the mean tumor size 9.35 ± 3.87 mm<sup>2</sup>, which was significantly decreased to 5.85 ± 0.95 mm<sup>2</sup> by the ER stress inhibitor 4-phenylbutyric acid (4PBA). …”
  15. 70875

    Table_6_PDIA2 Bridges Endoplasmic Reticulum Stress and Metabolic Reprogramming During Malignant Transformation of Chronic Colitis.xlsx by Jie Tao (227070)

    Published 2022
    “…</p>Results<p>AOM/DSS treatment induced 38 tumors in 10 mice at the 14th week with the mean tumor size 9.35 ± 3.87 mm<sup>2</sup>, which was significantly decreased to 5.85 ± 0.95 mm<sup>2</sup> by the ER stress inhibitor 4-phenylbutyric acid (4PBA). …”
  16. 70876

    Table_9_PDIA2 Bridges Endoplasmic Reticulum Stress and Metabolic Reprogramming During Malignant Transformation of Chronic Colitis.xlsx by Jie Tao (227070)

    Published 2022
    “…</p>Results<p>AOM/DSS treatment induced 38 tumors in 10 mice at the 14th week with the mean tumor size 9.35 ± 3.87 mm<sup>2</sup>, which was significantly decreased to 5.85 ± 0.95 mm<sup>2</sup> by the ER stress inhibitor 4-phenylbutyric acid (4PBA). …”
  17. 70877

    Image_2_PDIA2 Bridges Endoplasmic Reticulum Stress and Metabolic Reprogramming During Malignant Transformation of Chronic Colitis.tif by Jie Tao (227070)

    Published 2022
    “…</p>Results<p>AOM/DSS treatment induced 38 tumors in 10 mice at the 14th week with the mean tumor size 9.35 ± 3.87 mm<sup>2</sup>, which was significantly decreased to 5.85 ± 0.95 mm<sup>2</sup> by the ER stress inhibitor 4-phenylbutyric acid (4PBA). …”
  18. 70878

    Table_1_PDIA2 Bridges Endoplasmic Reticulum Stress and Metabolic Reprogramming During Malignant Transformation of Chronic Colitis.xlsx by Jie Tao (227070)

    Published 2022
    “…</p>Results<p>AOM/DSS treatment induced 38 tumors in 10 mice at the 14th week with the mean tumor size 9.35 ± 3.87 mm<sup>2</sup>, which was significantly decreased to 5.85 ± 0.95 mm<sup>2</sup> by the ER stress inhibitor 4-phenylbutyric acid (4PBA). …”
  19. 70879

    Table_4_PDIA2 Bridges Endoplasmic Reticulum Stress and Metabolic Reprogramming During Malignant Transformation of Chronic Colitis.docx by Jie Tao (227070)

    Published 2022
    “…</p>Results<p>AOM/DSS treatment induced 38 tumors in 10 mice at the 14th week with the mean tumor size 9.35 ± 3.87 mm<sup>2</sup>, which was significantly decreased to 5.85 ± 0.95 mm<sup>2</sup> by the ER stress inhibitor 4-phenylbutyric acid (4PBA). …”
  20. 70880

    Table_8_PDIA2 Bridges Endoplasmic Reticulum Stress and Metabolic Reprogramming During Malignant Transformation of Chronic Colitis.docx by Jie Tao (227070)

    Published 2022
    “…</p>Results<p>AOM/DSS treatment induced 38 tumors in 10 mice at the 14th week with the mean tumor size 9.35 ± 3.87 mm<sup>2</sup>, which was significantly decreased to 5.85 ± 0.95 mm<sup>2</sup> by the ER stress inhibitor 4-phenylbutyric acid (4PBA). …”